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Abstract
Background: Cognitive impairment is one of the main consequences of obstructive sleep apnea (OSA) and is
usually attributed in part to the oxidative stress caused by intermittent hypoxia in cerebral tissues. The presence of
oxygen-reactive species in the brain tissue should be produced by the deoxygenation-reoxygenation cycles which
occur at tissue level during recurrent apneic events. However, how changes in arterial blood oxygen saturation
(SpO2) during repetitive apneas translate into oxygen partial pressure (PtO2) in brain tissue has not been studied.
The objective of this study was to assess whether brain tissue is partially protected from intermittently occurring
interruption of O2 supply during recurrent swings in arterial SpO2 in an animal model of OSA.
Methods: Twenty-four male Sprague-Dawley rats (300-350 g) were used. Sixteen rats were anesthetized and non-
invasively subjected to recurrent obstructive apneas: 60 apneas/h, 15 s each, for 1 h. A control group of 8 rats was
instrumented but not subjected to obstructive apneas. PtO2 in the cerebral cortex was measured using a fast-
response oxygen microelectrode. SpO2 was measured by pulse oximetry. The time dependence of arterial SpO2
and brain tissue PtO2 was carried out by Friedman repeated measures ANOVA.
Results: Arterial SpO2 showed a stable periodic pattern (no significant changes in maximum [95.5 ± 0.5%; m ± SE]
and minimum values [83.9 ± 1.3%]). By contrast, brain tissue PtO2 exhibited a different pattern from that of arterial
SpO2. The minimum cerebral cortex PtO2 computed during the first apnea (29.6 ± 2.4 mmHg) was significantly
lower than baseline PtO2 (39.7 ± 2.9 mmHg; p = 0.011). In contrast to SpO2, the minimum and maximum values of
PtO2 gradually increased (p < 0.001) over the course of the 60 min studied. After 60 min, the maximum (51.9 ± 3.9
mmHg) and minimum (43.7 ± 3.8 mmHg) values of PtO2 were significantly greater relative to baseline and the first
apnea dip, respectively.
Conclusions: These data suggest that the cerebral cortex is partially protected from intermittently occurring
interruption of O2 supply induced by obstructive apneas mimicking OSA.
Background
Obstructive sleep apnea (OSA) is a very prevalent dis-
ease caused by recurrent events of upper airway
obstruction. One of the main physiological conse-
quences of the ventilation disruptions associated with
obstructive apneas is that the patient experiences events
of repetitive oxygen desaturation in arterial blood during
sleep. Recurrent hypoxemia - occurring once per minute
or even more frequently in patients with severe OSA -
induces oxidative stress, which has been related to the
inflammation, metabolic syndrome and cardiovascular
risk observed in patients with this sleep breathing
disorder [1,2]. Cognitive impairment is one of the well-
known consequences of OSA [3]; this is usually attribu-
ted to the oxidative stress caused by intermittent
hypoxia in cerebral tissues [4-6].
The mechanisms of oxidative stress genesis in OSA
are not known, but it is commonly accepted that the
deoxygenation-reoxygenation cycles produce swings in
the genesis of oxygen-reactive species, as in the case of
the ischemia-reperfusion processes [7,8]. Thus, a close
relationship between oscillations in tissue oxygen partial
pressure (PtO2) and the magnitude of the oxidative
stress during recurrent obstructive apneas should be
expected in any given tissue. There are no data, how-
ever, for PtO2 values in brain tissue, which is the vari-
able that most directly quantifies the oxygen available to
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oxygen saturation (SpO2) by recurrent apneas can be
measured by pulse oximetry, we do not know how
changes in arterial SpO2 translate into PtO2 in brain tis-
sue. In fact, the relationship between these two variables
could be modulated by rapid changes in cerebrovascular
hemodynamics in response to hypoxia and hypercapnia
[9-11]. It could therefore be possible that a physiological
response in the cerebral hemodynamics compensates, at
least in part, for the reduction in arterial SpO2 experi-
enced during repeated obstructive events in OSA.
Accordingly, the aim of this work was to test the
hypothesis that brain tissue PtO2 is partially protected
from intermittently occurring interruption of O2 supply
during recurrent arterial blood oxygen desaturations.
Given the invasiveness required to make direct measure-
ments of PtO2 in the brain cortex, the study was carried
out in an animal model that mimicked the obstructive
apneas characteristic of patients with OSA.
Methods
Animals
This study, which was approved by the Ethics Commit-
tee of Animal Experimentation of the University of Bar-
celona, was carried out on 24 Sprague-Dawley male rats
(300-350 g). The animals were anesthetized intraperito-
neally with Urethane 10% (1 g/Kg) and at the end of the
study they were sacrificed by ex-sanguination.
Measurement of O2 partial pressure in brain tissue
The head of the anesthetized rat was immobilized in
prone position and a small orifice was carefully made in
t h ed u r at oe x p o s et h ec e r e b r a lc o r t e x .Am o d i f i e d
Clark’s polarographic fast-response oxygen micro-elec-
trode pipette (OX-50, Unisense A/S, Denmark; 50 μm
diameter, 90% response time <2 s) was used to measure
cerebral cortex PtO2. The oxygen micro-electrode was
connected to an amplified picoammeter (Unisense A/S,
Denmark) and was calibrated before each experiment in
water at 100% and 21% and oxygen-free solution
(NaOH 0.1 M, sodium ascorbate 0.1 M) (MicOX soft-
ware, Unisense A/S, Denmark). The oxygen sensor,
mounted on a micrometric positioner, was inserted ver-
tically 2 mm from the surface of the cerebral cortex and
was then slightly retracted (≈ 0.5 mm) to a point where
as t a b l ev a l u eo fP t O 2was attained within the 30-50
mmHg range. A pulse oxymeter was positioned in the
rat leg to measure arterial blood saturation (504; Critical
Care Systems, Inc., Waukesha, WI). The arterial SpO2
and brain tissue PtO2 signals were sampled at 60 Hz
and stored for subsequent analysis.
Application of obstructive apneas
A previously described method was used to subject the
rats to a pattern of non-invasive recurrent obstructive
apneas: 60 apneas/h lasting 15 s each for a total time of
1 h [12]. This model was based on a nasal mask with
two tubes, one open to the atmosphere and the other
connected to an airflow source to avoid rebreathing. To
generate controlled obstructive apneas, two electroni-
cally synchronized electrovalves positioned in each tube
were closed (airway obstruction) or opened (sponta-
neous breathing). Sixteen rats were subjected to obstruc-
tive apneas and another eight rats, used as controls,
were identically instrumented but the valve-system in
the nasal mask did not apply airway obstructions.
Data processing
Both arterial SpO2 and cerebral cortex PtO2 were mea-
sured at baseline and at the minimum and maximum
attained during the first ten apneas and during the fol-
lowing apneas every 10 min up to 1 h. Results are
shown as mean ± SE. The time dependence of arterial
SpO2 and brain tissue PtO2 was carried out by Friedman
repeated measures ANOVA by comparing the sample
points at the first apnea and every 10 min up to 1 h
with respect to the steady state at the beginning of the
experiment. Comparisons were undertaken by means of
the Student-Newman-Keuls method, where appropriate.
Results
As expected, no significant changes were observed in
the control group in either SpO2 ( 9 5 . 6±0 . 5v s9 6 . 0±
0.5%) or PtO2 (42.8 ± 3.3 vs 43.1 ± 6.1 mmHg) between
the baseline and after 60 min of spontaneous breathing
with no apneas, respectively (Fig. 1).
Figure 2 shows an example of the data recorded dur-
ing the first 10 min after application of recurrent apneas
in a representative rat. Arterial SpO2 exhibited a stable
recurrent pattern (Fig. 2, top). Each apnea was reflected
by a fast decrease in SpO2 followed by a recovery, with
minimum and maximum values typical of patients with
OSA [13]. Brain tissue PtO2 followed a periodic time
course similar to that of arterial SpO2,b u tat r e n d
toward increasing PtO2 was apparent (Fig. 2, bottom).
Figure 3 shows the average data obtained in the group
of 16 rats subjected to recurrent apneas for 60 min. Arter-
ial SpO2 showed a stable periodic pattern (no changes in
maximum and minimum values). There was no signifi-
cant difference between the baseline and the maximum
values attained after recovery from each apnea. Moreover,
no significant differences were found between the mini-
mum values in arterial SpO2 attained during the different
apneas. By contrast, brain tissue PtO2 exhibited a differ-
ent pattern from that of arterial SpO2 (Fig. 3, bottom).
During the first apnea (at time 1 min), PtO2 was consider-
ably reduced to a minimum value of 29.6 ± 2.4 mmHg
(range 13.5 - 47.7 mmHg) from baseline (39.7 ± 2.9
mmHg) (range 25.5 - 64.0 mmHg). In the following
apneas, minimum and maximum values of PtO2 progres-
sively increase (both, p < 0.001). After the first 10 min of
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attained by PtO2 after the apnea (46.5 ± 3.7 mmHg)
(range 28.2 - 76.5 mmHg) was significantly greater (p <
0.05) than baseline and this difference increased further
throughout the experiment (PtO2 after the apnea was
51.9 ± 3.9 mmHg at 60 min) (range 34.5 - 84.9 mmHg).
The minimum values attained by PtO2 in each apnea fol-
lowed a pattern similar to that of the maximum values:
from 29.6 ± 2.4 mmHg (range 13.5-47.7 mmHg) during
the first apnea to 43.7 ± 3.8 mmHg (range 29.1-83.1
mmHg) at 1 h (p < 0.05). The magnitude of the PtO2
swings showed no significant dependence on time over
the course of the experiment.
Discussion
We found that cerebral tissue PtO2 followed a pattern of
changes markedly different from that of arterial SpO2
when the animals were subjected to recurrent
obstructive apneas mimicking OSA (Fig. 3). Indeed, dur-
ing the first obstructive apnea there was an immediate
transient reduction in the oxygen partial pressure in
brain tissue; this was quickly restored during reoxygena-
tion. In contrast to SpO2, the maximum and minimum
values observed in PtO2 during the following apneas
experienced an increase with respect to the basals, indi-
cating that the brain was partially protected from the
intermittent interruption of O2 supply during recurrent
arterial oxygen desaturations.
Although changes in the PtO2 of several tissues were
previously measured in models of hypoxia, endotoxemia
and hemorrhage [14-18], no data describing how brain
tissue PtO2 is affected by airway obstructions mimicking
OSA were available before the present study. To carry out
this work we used a previously described non-invasive
animal model [12] specifically designed to apply recurrent
obstructive apneas in a stable and controlled manner, free
from confounding factors caused by the comorbidities
Figure 1 Time course of the values of arterial oxygen
saturation (SpO2) and brain tissue O2 partial pressure (PtO2)
recorded in control rats. No changes were found in SpO2 and
PtO2 values over the 60 min of the experiment. Results are shown
as mean ± SE (n = 8). The time dependence of arterial SpO2 and
brain tissue PtO2 was assessed with a Friedman repeated measures
ANOVA by comparing sample points at the first apnea and during
the apneas at minute 10 and every 10 min up to 1 h with respect
to baseline.
Figure 2 Example of oxygen arterial saturation (SpO2)a n d
brain tissue O2 partial pressure (PtO2) signals recorded during
the first ten minutes from a rat subjected to recurrent
obstructive apneas. The SpO2 dips, mimicking those observed in
OSA patients, were paralleled by similar dips in PtO2. However,
while maximum and minimum values in SpO2 showed a stable
pattern (top), PtO2 exhibited a progressive tendency to increase
(bottom).
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in this model were anesthetized could affect the systemic
cardio-respiratory response to occlusions when compared
with non-anesthetized animals. Accordingly, the response
to recurrent obstructive apneas in terms of resulting
arterial SaO2 could be slightly different in anesthetized
and non-anesthetized animals. However, the SaO2 signals
recorded in our anesthetized rats concur to a reasonable
extent with the ones observed in OSA patients experien-
cing a pattern of obstructive apneas similar to the one
applied to our rats (60 apneas/h lasting 15 s each). In con-
trast with animal models in which hypoxia/reoxygenation
was applied by periodically changing the O2 concentra-
tion of the breathed air, the model used in this study
applied actual obstructive apneas [19]. Accordingly, this
model was able to mimic the respiratory events in OSA
patients more realistically. Indeed, in addition to intermit-
tent hypoxia, the animal experienced increased inspira-
tory efforts to breathe against a periodically obstructed
airway and was exposed to the recurrent hypercapnia
associated with obstructive apneas. This is particularly
relevant here since these two stimuli have potential sys-
temic and cerebral hemodynamic effects [10,20] that
could alter the relationship between arterial SpO2 and
brain tissue PtO2.
Given the heterogeneity in brain tissue oxygen tension
[21], in order to measure the time course of cerebral
cortex PtO2 we focused our attention on tissue places
with baseline values within the range of 30-50 mmHg,
which are the most representative values observed in
the majority of tissues (including the brain) during nor-
moxia [22,23]. The modified Clark’s micro-electrode
oxygen sensor is particularly suited to the measurement
of brain PtO2 [10,14,24-26]. When compared with tech-
niques requiring chronic implantation of paramagnetic
oxygen-sensitive material in the tissue under study (elec-
tron paramagnetic resonance technique) [22], a micro-
electrode is minimally invasive and induces minimal tis-
sue trauma [27], as reflected by the stable PtO2 values
obtained in the control rats. One advantage of the
micro-electrode technique is that its small size (50 μm)
allows the measurement of brain tissue PtO2 at a micro-
regional level, in contrast to the near-infrared spectro-
scopic technique, which explores a greater tissue volume
and may therefore include large blood vessels [28,29].
One important feature of the specific micro-electrode
oxygen sensor used in this work is that its rapid
response time (90% response in less than 2 s) allowed
us to accurately determine the rapid changes induced in
PtO2 during recurrent obstructive apneas.
The gradual increase in brain tissue PtO2 was signifi-
cant within the first 10 apneic episodes (10 min)
(Fig. 3). This response time falls within the time scale of
previously reported cerebrovascular and physiological
oxygenation responses to ventilatory challenges. In fact,
it was reported that cerebral blood flow increased
almost immediately after the application of acute isocap-
nic hypoxia to healthy volunteers [11]. Moreover, the
low values of brain PtO2 induced by hemorrhage in a
swine model (PtO2 decreased from 40 mmHg at base-
line to 5 mmHg) were recovered in only ≈ 10 min [14],
while brain PtO2 in rats exhibited a fast response when
subjected to changes in the concentration of O2 and
CO2 in inspired air; the increase in PtO2 was also CO2
dose-dependent [10]. In this respect, it should be
stressed that our model would produce an increase in
blood PCO2 concomitant with oxygen desaturation.
Hypercapnia may amplify the effects of hypoxemia on
brain blood flow, thereby attenuating the impact of sys-
temic hypoxia on PtO2 drops in the brain [30]. Never-
theless, it should be mentioned that prolonged
hypercapnia tends to blunt the vasodilatating effect of
CO2 [31,32]. Although, to our knowledge, there are no
Figure 3 Time course of the maximum (Δ) and minimum (▼)
values of arterial oxygen saturation (SpO2) and brain tissue O2
partial pressure (PtO2) recorded during each obstructive apnea.
A schematic representation of the corresponding dips in both
variables is superimposed for the purpose of clarity. Baseline value is
represented by an open circle. Maximum and minimum values of
PtO2 experienced a time-dependent increase (both, p < 0.001). In
contrast, no changes were found in SpO2 maximum and minimum
values. Results are shown as mean ± SE (n = 16). The time
dependence of arterial SpO2 and brain tissue PtO2 was assessed
with Friedman repeated measures ANOVA by comparing sample
points at the first apnea and during the apneas at minute 10 and
every 10 min up to 1 h with respect to baseline for maximum
values or first event for minimum values. Comparisons were
undertaken by means of the Student-Newman-Keuls method. * p <
0.05 respect to baseline p < 0.05 respect to the first apneic event. h
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found in OSA to CO2 regulation of cerebral blood flow,
alterations in the cerebral perfusion of OSA patients are
well documented [33]. Interestingly, the potential effect
of hypercapnia modulating the cerebral flow and the
mechanical stimuli characterizing obstructive apneas
could be tested in future studies by subjecting animals
to intermittent hypoxia without any airway obstructions.
The observed response was only partially effective in
protecting brain tissue from deoxygenation-reoxygena-
tion cycling. Indeed, despite the fact that brain PtO2
showed a tendency to increase, PtO2 swings were still
found in brain tissue (Fig. 3), potentially explaining the
increase in reactive oxygen species (or the oxidative
stress damage) encountered in brain tissue by other
authors [4,5]. At the outset, it would appear that the
magnitude of PtO2 decrease in the desaturation valleys
is not enough to trigger an ischemia-like process. With
the PtO2 recorded in our experiments an alteration in
electron transport with subsequent energetic derange-
ment and loss of cell ion gradients should not be
expected, owing to the high O2 affinity of cytochrome
oxidase [34,35]. Similarly, an anomalous activation of
reactive oxygen species generating enzymes in the cell
cytoplasm is not conceivable as there is no basis to the
suspicion of alterations in intracellular Ca
2+ homeostasis
or exhaustion of cell NAD
+ in the reoxygenation phase
of the obstruction [36,37]. Yet, as mentioned above, it is
possible that the protective effect of hypercapnia via an
increase in cerebral blood flow may progressively decline
with the duration of OSA, and hemoglobin desaturation
could therefore be directly transmitted to brain tissue
PO2: i.e., in the long run a certain level of brain hypoxia,
and thereby of oxidative stress, may occur. Another
potential factor in the genesis of reactive oxygen species
in this situation is inflammation. It is well documented
that OSA patients and intermittent hypoxia models have
sensitized leukocytes [38,39] that produce higher
amounts of reactive oxygen species at rest and under
stimulation, and an increased expression of inflamma-
tory cytokines and soluble adhesion molecules [40].
Consistent with this suggestion, it has been reported
that short episodes of hypoxia (a total of 12 apneas of
30 s each) cause a dramatic increase in the number of
leukocytes adhering to brain microvessels [41,42]. Thus,
hypoxemia-induced leukostasis in brain microcirculation
and sensitization of leukocytes can satisfactorily explain
the genesis of oxidative stress, despite the maintenance
of PtO2. This oxidative stress in turn can be pathogenic
to the cognitive deterioration (and other neurological
alterations) observed in botha n i m a lm o d e l s[ 4 , 5 ]a n d
patients with OSA [3]. It is worth pointing out, in this
respect, that intermittent hypoxia, such as the one
detected regardless of a trend toward increasing PtO2
(Fig. 3), is more deleterious, for similar levels of hypoxia,
than constant hypoxia [7,43].
As it is impossible to measure brain tissue PtO2 non-
invasively in humans, the only available data on brain
oxygenation in patients with OSA were obtained by mea-
suring indirect variables. For instance, blood flow in cere-
bral artery measured by transcranial Doppler [44,45] or
brain tissue total hemoglobin and oxyhemoglobine mea-
sured by near-infrared spectroscopy [28,29]. These find-
ings showed that the values observed by these indirect
measurements of brain oxygenation were lower in
patients with sleep disorder breathing than in healthy per-
sons. The differences between groups could be masked,
however, by confounding factors such as age and obesity,
which have been shown to modify cerebral hemody-
namics [46-49] and cerebrovascular autoregulation in
patients with OSA [45]. Interestingly, the application of
the methodological approach devised in the present work
to hypertensive, obese, diabetic or old rats could be useful
for investigating how comorbidities typically found in
OSA interact with physiological mechanisms to partially
protect brain tissue from recurrent apneas.
Conclusions
We found that the oxygen partial pressure in the brain
tissue of rats subjected to recurrent obstructive apneas
mimicking OSA is partially protected from intermittent
interruption of O2 supply during dips in oxygen desa-
turation found in arterial blood. This phenomenon,
whose effectiveness could be reduced by common
comorbidities, could play a role in modulating the neu-
rocognitive consequences of OSA.
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